Blog
August 9, 2026
Dry eye is often discussed as if it had one cause and one solution. In practice, two people with the same burning sensation may have very different problems. One produces too little aqueous fluid because of autoimmune lacrimal-gland disease. Another produces adequate fluid but loses it rapidly because obstructed eyelid oil glands provide an unstable lipid layer. A third has incomplete closure after surgery, and a fourth has corneal nerve sensitization after the surface has largely healed.
The useful question is therefore not only “Do I have dry eye?” It is “Which processes are making my tear film unstable, and which of them can safely change?” This cause-focused guide complements Netra Eye Institute’s dry-eye condition page without repeating a general disease overview.
The tear film depends on lacrimal secretion, meibomian lipids, conjunctival mucins, intact epithelium, corneal sensation, coordinated blinking, eyelid closure and appropriate drainage. These structures communicate as the lacrimal functional unit.
A contributor can disrupt one or several links:
Most chronic cases are mixed. Naming a single risk factor does not prove causation, and removing one exposure may not reverse gland loss or an established inflammatory cycle.
Digital devices are frequently blamed for dry eye, and the association is biologically plausible. Concentrated near work reduces spontaneous blink rate and increases incomplete blinks. The lower cornea remains exposed longer, while meibomian secretion is distributed less effectively. Symptoms accumulate with task duration and may improve after closing the eyes or changing environment.
Other screen-related variables matter:
Ordinary screens have not been shown to cause dry eye by damaging the retina with blue light. Blue-blocking spectacles do not restore meibomian lipids or make a person blink completely. The practical response is behavioral and environmental: lower the screen slightly, increase comfortable text size, interrupt sustained staring and perform several slow full blinks.
The 20-20-20 rule can serve as a reminder, but its distance component is mainly directed at accommodative strain. No specific timing formula has been proved to fit every worker. A deliberate reset every 20 to 30 minutes is more useful than perfect compliance with a slogan followed by hours of unbroken work. See the separate guide to screens, blue light and eye health.
Evaporation rises when relative humidity is low or air moves rapidly across the eye. Heating, air conditioning, ceiling fans, vehicle vents, hair dryers and aircraft cabins can therefore provoke symptoms. A person with healthy reserve may tolerate these conditions, while someone with gland dysfunction reaches breakup quickly.
Smoke and particulate pollution can irritate the surface and are associated with dry-eye symptoms in epidemiologic research. Wildfire smoke, tobacco smoke, industrial dust and volatile chemicals can add oxidative and inflammatory stress. Occupational risk depends on concentration, duration, eye protection and ventilation.
Cold wind combines low humidity and airflow. Hot climates are not automatically protective because air conditioning, dust and sun exposure may dominate. Wraparound glasses, redirecting vents, appropriate workplace controls and a humidifier in a genuinely dry room can reduce stress. A poorly cleaned humidifier can disperse microbes or allergens, so maintenance matters.
Allergy complicates the picture. Pollen or indoor allergens produce itching, swelling and watery discharge, while oral antihistamines may reduce tear secretion. Eye rubbing adds mechanical trauma. Treating allergy and dry eye together is different from repeatedly using redness-relief drops, which constrict vessels without correcting either cause.
Medication lists are essential because systemic and topical drugs can affect lacrimal secretion, meibomian glands, mucosa, epithelium, eyelids or sensation. Evidence ranges from strong clinical patterns to observational associations confounded by the disease being treated.
Acetylcholine participates in lacrimal secretion. Medicines with anticholinergic activity—including some bladder drugs, gastrointestinal antispasmodics, sedating antihistamines, tricyclic antidepressants and other psychiatric medicines—can reduce secretory drive. The combined burden of several agents may matter more than one drug.
This does not mean every person taking an antidepressant or antihistamine will develop dry eye. Depression, allergy, age and other conditions may themselves correlate with symptoms. A prescriber can assess dose, timing and alternatives while protecting the reason the medicine was prescribed.
Systemic isotretinoin is well known to cause mucocutaneous dryness and can alter meibomian-gland function. Symptoms may include dryness, blepharitis, contact-lens intolerance and reduced night comfort. Most acne patients still need a balanced dermatologic decision; some require baseline counseling, surface support or eye evaluation during treatment.
Topical facial retinoids are not equivalent to systemic isotretinoin, but migration toward the lid margin and individual susceptibility warrant practical caution. Products should not be placed in the eye or directly over gland openings unless specifically designed and advised for that use.
Diuretics, beta blockers and other cardiovascular medicines have been associated with dryness in some studies, but effects are inconsistent and systemic disease confounds interpretation. Blood-pressure medicine can prevent stroke, heart failure and kidney injury. Dry-eye symptoms are not a reason to stop it independently.
Cancer therapies—including immune checkpoint inhibitors, taxanes, epidermal growth factor receptor inhibitors and other targeted agents—can cause distinct ocular-surface toxicities. New symptoms during cancer treatment deserve communication among oncology and eye-care teams rather than an over-the-counter-only approach.
Chronic glaucoma drops, antibiotic exposure and frequent preserved lubricants can affect the ocular surface. Benzalkonium chloride and other preservatives help maintain bottle sterility but may add epithelial or inflammatory burden with frequent long-term use. The answer is not to stop pressure-lowering medication. Clinicians can consider technique, preservative-free formulations, combination products, laser or other strategies based on the underlying disease.
Vasoconstrictor “get the red out” drops can produce rebound redness or mask persistent disease. Topical anesthetic drops are toxic with repeated unsupervised use and must never be used as home pain treatment.
Dry-eye prevalence rises with age. Lacrimal secretion, meibomian structure, blink dynamics, eyelid position, corneal nerves and medication exposure all change across adulthood. Aging also increases cataract, macular and neurologic conditions that can mimic or compound visual complaints.
Sex hormones influence lacrimal and meibomian tissues. Dry eye is more prevalent in women, particularly after menopause, but the relationship is not a simple estrogen-deficiency equation. Androgens, estrogen balance, receptor expression, inflammation and systemic therapy interact. Hormone replacement can improve one health problem while having neutral or adverse ocular associations in some studies.
Pregnancy and oral contraceptives may alter symptoms and contact-lens tolerance. Any treatment decision must consider reproductive safety; oral herbs, tetracyclines, retinoids and prescription drops are not automatically safe in pregnancy or breastfeeding.
Meibomian-gland dysfunction is a major driver of evaporative dry eye. Gland openings become obstructed, meibum thickens, secretion decreases and glands may shorten or drop out over time. Aging, rosacea, blepharitis, Demodex infestation, contact lenses and medications can contribute.
Rosacea may be subtle on the skin while lid-margin telangiectasia and gland inflammation are prominent. Demodex mites are common with age, but excessive infestation can produce cylindrical lash debris and inflammation. Treatment differs from ordinary soap-and-water lid hygiene; concentrated tea tree oil around the eye can irritate and should not be improvised.
Eyelid anatomy affects exposure. Ectropion turns the lid outward, entropion turns it inward, and laxity can impair tear distribution and drainage. Thyroid eye disease or orbital anatomy may increase exposure. Facial nerve palsy can prevent complete closure. These are mechanical problems; no amount of oral hydration substitutes for lid protection or repair when needed.
Contact lenses alter tear distribution, increase evaporation from the pre-lens surface and can create friction or solution-related irritation. Risk depends on material, fit, replacement, deposits, wear time, environment and the preexisting surface.
Sleeping in lenses, water exposure and poor hygiene increase infection risk, not merely dryness. A painful red photophobic contact-lens eye needs urgent corneal evaluation. For nonurgent intolerance, the clinician may address surface disease, adjust material or schedule, change care solution, reduce wearing time or fit a specialty design.
Discomfort should not be overcome with anesthetic or nonsterile drops. Preservative compatibility and lens labeling matter because not every lubricant is approved for use while lenses are worn.
LASIK, PRK, cataract surgery, eyelid surgery, corneal transplantation and other procedures can temporarily or persistently alter sensation, blinking, exposure, inflammation and topical medication load. Preexisting dry eye predicts more postoperative symptoms and less reliable preoperative measurements.
After corneal refractive surgery, severed nerves gradually recover, but timelines and symptom patterns vary. Reduced sensation can lower reflex tearing; abnormal regeneration may contribute to dysesthesia. Cataract incisions are smaller but the combination of drops, surface preparation and inflammation can still provoke disease.
Persistent severe pain with few signs is not proof that “nothing is wrong.” It should prompt evaluation for neuropathic ocular pain and other diagnoses. Conversely, attributing all postoperative discomfort to nerves can miss infection, retained foreign material, erosion or inflammation.
Sjögren disease causes immune-mediated dysfunction of lacrimal and salivary glands and can affect multiple organs. Dry mouth, dental caries, salivary swelling, fatigue, joint symptoms, neuropathy or systemic features raise suspicion, but not every patient has every symptom or positive antibody.
Rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, inflammatory bowel disease, graft-versus-host disease and other immune disorders can be associated with ocular-surface disease through different mechanisms. Cicatrizing autoimmune disease can threaten vision by scarring conjunctiva and damaging lids, goblet cells and cornea.
The eye-care professional may coordinate laboratory work or rheumatology referral when the pattern warrants it. A negative screening antibody does not universally exclude Sjögren disease. The separate article on dry eye, autoimmune disease and Sjögren’s explains that pathway in depth.
Diabetes can affect lacrimal secretion, corneal innervation, epithelial healing and meibomian function. Reduced sensation may hide injury, while unstable glucose can blur vision through lens changes. Retinopathy or macular edema must also be considered when vision fluctuates.
Thyroid eye disease can retract lids, increase exposure and prevent complete closure. Symptoms may persist even when thyroid blood tests are controlled because orbital and eyelid changes have their own activity and recovery. New double vision, color change, pain with eye movement or reduced vision requires specialist evaluation.
Parkinson disease, stroke and other neurologic conditions can reduce blink frequency or closure. Vitamin A deficiency, uncommon in well-nourished U.S. adults, can seriously disrupt epithelial and goblet-cell health and may arise from malabsorption, liver disease or restrictive intake. Blind supplementation is unsafe because excessive preformed vitamin A is toxic.
Sleep apnea does not have one uniform dry-eye mechanism. Mask leak can direct air toward the eyes, while floppy eyelid syndrome and nocturnal exposure may coexist. Adjusting mask fit is preferable to abandoning medically necessary positive-airway-pressure therapy.
True dehydration can reduce secretions, and adequate fluid intake is part of general health. But most chronic dry eye is not caused by failing to drink an arbitrary number of glasses. Excess water cannot reopen obstructed meibomian glands or reverse autoimmune lacrimal damage.
Omega-3 supplements have mixed evidence. The large DREAM trial found no advantage of high-dose fish-derived omega-3 over an olive-oil control for moderate-to-severe dry eye, while later meta-analyses combining heterogeneous trials have reported improvements in selected signs or symptoms. Product formulation, baseline diet, phenotype and study methods differ. Supplements also have cost, gastrointestinal and bleeding considerations.
A balanced dietary pattern that supports cardiometabolic health is reasonable, but food should not be marketed as a replacement for corneal protection or anti-inflammatory treatment. The lifestyle article addresses evidence and limits in more detail.
A cause-focused visit reconstructs time. When did symptoms begin? Did they follow a medicine, surgery, infection, move, new office, contact-lens change or hormonal transition? Are they worse on waking, late in the day, outdoors or during concentrated work? Is itching, pain, discharge, dry mouth or joint disease present?
The examination looks for tear instability, staining pattern, meniscus volume, meibum quality, gland structure, lid position, closure, lash debris, allergy, corneal sensation and alternative diagnoses. Selected tests refine the picture; no single test identifies every contributor.
A useful causal map separates:
This prevents both extremes: dismissing lifestyle entirely and blaming lifestyle for disease the patient did not cause.
Symptoms do not obey a perfect schedule, but timing provides useful clues. Discomfort that builds late in the workday often reflects cumulative evaporation, reduced blinking, contact-lens wear or medication exposure. Morning pain may point toward nocturnal exposure, CPAP leak, recurrent corneal erosion or overnight inflammatory changes. Burning immediately after a particular drop raises questions about its active ingredient, pH, preservative or an already damaged epithelium.
Seasonal worsening can reflect forced-air heating, low outdoor humidity or allergy. Symptoms that improve on vacation may implicate an office environment or task pattern, but travel itself changes sleep, climate, screen time and adherence. Menstrual, pregnancy or menopausal patterns may suggest hormonal contribution without proving that hormone therapy is the answer.
Laterality also matters. Common dry eye can be asymmetric, yet a strikingly one-sided presentation asks for local explanations: facial nerve weakness, prior surgery, lid malposition, contact-lens fit, blocked drainage, retained foreign body, herpetic disease, exposure or a focal corneal problem. A unilateral painful red eye should not be normalized as routine dryness.
Keeping a two-week diary is often more informative than trying to remember an average day. Record waking symptoms, medication and drop timing, contact-lens hours, major tasks, room or outdoor conditions, sleep quality and any systemic flare. The purpose is not to create a burdensome lifelong log. It is to test plausible relationships before spending money or changing important treatment.
“Do you use a computer?” is too broad. An accountant looking down at a laptop in a quiet room has different exposure from a machinist facing fans and particulate matter, a hair stylist working with aerosols, a laboratory worker in controlled low humidity or a driver receiving constant dashboard ventilation.
Healthcare workers may wear masks that direct exhaled air upward, increasing evaporation around the eyes. Protective eyewear can reduce that airflow but may fog, changing visual behavior. Pilots and flight crew encounter low cabin humidity; swimmers face chlorinated or contaminated water; cyclists and runners encounter wind; cooks face heat, smoke and steam. Woodworking, construction and yard work add dust and projectile risk.
The response must fit the hazard. Sealed or wraparound protection may reduce wind, while certified safety goggles protect against chemicals and particles. Ordinary fashion sunglasses are not chemical splash protection. Local exhaust ventilation is more effective than simply adding drops in a high-exposure workplace. Occupational-health involvement may be appropriate when symptoms consistently follow a documented work exposure.
Hobbies can matter as much as jobs. Long sewing, gaming, model building or music-reading sessions reduce blinking. Eyelash extensions, adhesives, cosmetic procedures and lid-margin makeup can trigger allergy, toxicity or gland obstruction. Asking without judgment helps identify exposures that patients may not consider “medicines.”
Viral conjunctivitis can temporarily destabilize tears and leave lingering irritation, but active infection may also cause redness, watery discharge and light sensitivity. Bacterial keratitis can initially be mistaken for severe dryness, especially by a contact-lens user. Herpes simplex and herpes zoster can alter corneal sensation, producing both epithelial disease and later neurotrophic or neuropathic problems.
Allergy is characterized by itch, yet chronic rubbing, mast-cell inflammation, oral antihistamines and preserved topical drops can create a dry-eye component. Treating only dryness may leave itch uncontrolled; treating only allergy with a drying systemic medicine may worsen tear instability. Clinicians sometimes choose topical allergy therapy, preservative reduction, cold compresses and environmental control while also treating the ocular surface.
Blepharitis is similarly broad. Anterior lash-line debris, seborrheic change, staphylococcal inflammation, Demodex and posterior meibomian disease are not interchangeable. “Wash your lids” is incomplete advice unless the product, technique, frequency and target are clear. Harsh detergents and excessive scrubbing can worsen irritation.
Correcting dehydration is important, but a hydrated bloodstream does not guarantee normal lacrimal secretion, meibomian lipids, mucins or closure. Urine color, thirst, kidney and heart conditions, climate and medications all affect appropriate fluid intake. Universal high-volume prescriptions can be unsafe for people with fluid restrictions.
Blocked drainage more often causes overflow tearing. Punctal plugs intentionally reduce drainage to conserve tears. Dry eye can coexist with drainage obstruction, so anatomy and tear quality both need assessment.
Redness is nonspecific. Dryness, allergy, infection, contact-lens hypoxia, episcleritis, scleritis, uveitis and angle closure can all redden the eye. The pattern, pain, vision, pupil, discharge and examination distinguish them.
No screening panel answers every case. Some patients with Sjögren disease are seronegative, and classification criteria are not identical to clinical diagnosis. Testing should follow the history and examination, with rheumatology or oral-medicine input when warranted.
Marketing sometimes uses meibography images to promise regeneration. Some gland appearance can change with imaging technique or reduced obstruction, but reliable restoration of established dropout is not an accepted routine outcome. Treatment aims to preserve and improve function of remaining glands, reduce obstruction and stabilize the surface.
Supplements and herbs can have anticholinergic, hormonal, allergic or drug-interaction effects. Essential oils and concentrated plant products near the lids can irritate. Natural origin does not establish ocular sterility, dose consistency or safety.
Dry-eye research contains many cross-sectional studies. If screen users report more symptoms, the association may reflect blink behavior, but it may also reflect occupation, sleep, contact lenses or healthcare-seeking. If people taking a medicine have worse signs, the underlying disease may contribute. Randomized withdrawal studies are rarely feasible for necessary therapy.
Clinicians therefore combine several forms of evidence: temporal relationship, biological plausibility, dose or exposure response, examination phenotype, improvement with safe modification and recurrence on re-exposure when that occurs unintentionally. No patient should be deliberately rechallenged with a dangerous exposure merely to prove a cause.
This careful language matters for SEO and patient trust. “May contribute” is often more accurate than “causes.” A risk factor can be clinically actionable without accounting for the entire disease.
Do not stop antidepressants, antihistamines, blood-pressure medicines, isotretinoin, glaucoma drops or cancer therapy without the prescribing clinician. Do not place tap water, saliva, homemade saline, herbal liquid, essential oil or nonsterile honey in the eye. Do not use someone else’s prescription drops.
Avoid assuming all redness is dryness. Infection, uveitis, scleritis and angle closure require different care. Avoid repeated unsupervised topical steroid use; steroids can raise eye pressure, promote cataract and worsen infection even when they temporarily reduce redness.
Netra Restoration Therapy (NRT) can complement a cause-specific medical plan by examining whole-person contributors such as sleep, stress, diet, screen behavior, environment, medication burden and systemic symptom patterns. Licensed acupuncture and individualized integrative care may be considered for selected patients after dangerous and treatable ophthalmic causes are addressed.
Research on acupuncture for dry eye includes randomized trials and systematic reviews reporting improvements in symptoms, breakup time or Schirmer measurements. Confidence is limited by variable diagnostic criteria, protocols, comparators, blinding and follow-up. It is reasonable to describe a monitored adjunctive trial; it is not reasonable to promise gland regeneration, medication replacement or cure.
NRT should work within co-management. Medication changes belong to the prescriber. Suspected Sjögren disease belongs in coordinated eye and rheumatology care. Exposure keratopathy may require lid protection or surgery. Infection and significant epithelial defects require conventional treatment. Integrative strategies should have a defined goal and stop rule, and they must never be used to explain away worsening signs.
Oral herbs or supplements can interact with anticoagulants, immune medicines, diabetes therapy and surgery. Pregnancy, liver or kidney disease and product quality require specific review. “Natural” does not mean sterile enough for ocular use or safe in every body.
Learn more about Netra Restoration Therapy for dry eye, Netra Eye Institute’s approach and how to request an appointment.
At home or work, document patterns before changing everything at once:
Track a few outcomes—comfortable screen minutes, drop frequency, evening pain, staining or breakup time—over a defined interval. Improvement after removing an exposure supports its relevance but does not prove it was the only cause.
Ordinary screen use is more closely linked to reduced and incomplete blinking than permanent gland destruction. Long-term behavior can aggravate an already vulnerable system, so addressing blink and environment still matters.
Not necessarily. Symptoms may improve when a reversible medication effect is removed, but underlying gland dysfunction, inflammation or another cause may persist. Any change must be coordinated with the prescriber.
Humidity, HVAC, allergens, pollution, work tasks and commuting can all change. The timing is a clue, not proof. A local examination can distinguish exposure from coincident disease.
Stress can change autonomic function, sleep, blinking, pain perception and health behaviors. Associations exist, but symptoms should not be labeled psychological without examining the ocular surface and systemic contributors.
Some episodes are temporary after illness, medication or surgery. Others recur because structural or autoimmune drivers persist. Early identification and sustained management can reduce burden even when there is no one-time cure.
NRT can contribute a whole-person history and adjunctive plan, but ocular diagnosis requires appropriate licensed examination and testing. It cannot infer autoimmune disease, infection, gland dropout or corneal nerve injury from symptoms alone.
Dry eye is an endpoint reached by many pathways. Screens alter blinking; environment changes evaporation; medicines alter secretion or tissues; systemic disease changes glands, nerves and epithelium; and eyelid anatomy determines exposure. The most effective plan identifies which pathways are active in one person and assigns each to the right intervention.
Remove avoidable stress, coordinate rather than abruptly change necessary medicines, protect the cornea and treat documented disease. NRT may add individualized supportive care, but precision includes knowing when conventional ophthalmology, rheumatology, dermatology, neurology or urgent care must lead.
Medical Disclaimer: This article is for general education and is not medical advice, diagnosis or a recommendation to stop medication. Discuss prescription, over-the-counter and supplement changes with the responsible clinician. Seek urgent eye care for sudden vision loss, severe or one-sided pain, marked light sensitivity, trauma, chemical exposure, purulent discharge or redness and pain during contact-lens use. Do not place nonsterile products in the eye. Netra Restoration Therapy is complementary and must not delay or replace ophthalmic, rheumatologic, dermatologic, neurologic, oncologic or emergency care.
